Therapy-refractory panic: Current research areas as possible perspectives in the treatment of anxiety

European Archives of Psychiatry and Clinical Neuroscience

Volumn 260, Issue SUPPL. 2, 2010, Pages

  Diemer, J ^a   Vennewald, N ^a   Domschke, K ^a   Zwanzger, P ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Agoraphobia; Cognitive behavioural therapy; Combined treatment; Pharmacological treatment; Transcranial magnetic stimulation; Virtual reality

Indexed keywords

IMIPRAMINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ANXIETY; CLINICAL TRIAL; COGNITIVE THERAPY; CONFERENCE PAPER; EXPOSURE; HUMAN; MAJOR DEPRESSION; OUTCOME ASSESSMENT; PANIC; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION;

ANTIMETABOLITES; BIOMEDICAL RESEARCH; COGNITION; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CYCLOSERINE; HUMANS; PANIC DISORDER; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 78449276667     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-010-0143-9     Document Type: Conference Paper

References (54)

1. RC Kessler WT Chiu R Jin, et al. 2006 The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication Arch Gen Psychiatry 63 415 424 10.1001/archpsyc.63.4.415 16585471
2. Bandelow B (2003) Epidemiology of depression and anxiety. In: Kasper S (ed) Handbook on depression and anxiety. M. Dekker, New York, pp 49-68
3. Barlow DH (2002) Anxiety and its disorders: the nature and treatment of anxiety and panic. Guilford Press, New York
4. W Katon 1996 Panic disorder: relationship to high medical utilization, unexplained physical symptoms, and medical costs J Clin Psychiatry 57 11 22 8917128
5. DS Baldwin IM Anderson DJ Nutt, et al. 2005 Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology J Psychopharmacol 9 567 596 10.1177/0269881105059253 (Pubitemid 41578819)
6. Bandelow B, Zohar J, Hollander E et al (2008) World federation of societies of biological psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders-first revision. World J Biol Psychiatry 9:248-312
7. JM Cloos 2005 The treatment of panic disorder Curr Opin Psychiatry 18 45 50 16639183
8. RP Mattick G Andrews D Hadzi-Pavlovic, et al. 1990 Treatment of panic and agoraphobia: an integrative review J Nerv Ment Dis 178 567 576 1:STN:280:DyaK3czmvFaqsA%3D%3D 10.1097/00005053-199009000-00003 2144315
9. RA Gould MO Otto MH Pollack 1995 A meta-analysis of treatment outcome for panic disorder Clin Psychol Rev 15 819 844 10.1016/0272-7358(95)00048-8 (Pubitemid 26011957)
10. JC Ballenger 1998 Treatment of panic disorder in the general medical setting J Psychosom Res 44 5 15 1:STN:280:DyaK1c7ksVCmsQ%3D%3D 10.1016/S0022-3999(97)00249-3 9483459 (Pubitemid 28029885)
11. B Bandelow E Rüther 2004 Treatment-resistant panic disorder CNS Spectr 9 725 739 15448584
12. McIntosh A, Cohen A, Turnbull N et al (2004) Clinical guidelines and evidence review for panic disorder and generalised anxiety disorder. National Collaborating Centre for Primary Care, Sheffield
13. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Panic Disorder and Agoraphobia (2003) Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia. Aust and N Z J Psychiatry 37:641-656
14. AKDÄ (2003) Therapieempfehlungen der Arzneimittelkommission der deutschen Ärzteschaft. Empfehlungen zur Therapie von Angst- und Zwangsstörungen
15. P Zwanzger J Diemer B Jabs 2008 Comparison of combined psycho-and pharmacotherapy with monotherapy in anxiety disorders: controversial viewpoints and clinical perspectives J Neural Transm 116 759 765 10.1007/s00702-008-0116-6 18810307
16. Furukawa TA, Watanabe N, Churchill R (2007) Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database of Syst Rev. doi: 10.1002/14651858.CD004364.pub2 (Pubitemid 351820420)
17. B Bandelow U Seidler-Brandler A Becker, et al. 2007 Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders World J Biol Psychiatry 8 175 187 10.1080/15622970601110273 17654408 (Pubitemid 47163383)
18. HP Kapfhammer 2008 Psychotherapy and pharmacotherapy of anxiety disorders Neuropsychiatry 22 51 70
19. Schneider S, Margraf J (1998) Agoraphobie und Panikstörung. Hogrefe, Göttingen
20. DM Clark 1986 A cognitive approach to panic Behac Res Ther 24 461 470 1:STN:280:DyaL283psFCntQ%3D%3D 10.1016/0005-7967(86)90011-2 (Pubitemid 16088586)
21. Ehlers A, Margraf J (1989) Psychophysiological model of panic attacks. Swets & Zeitlinger, Amsterdam
22. AT Gloster HU Wittchen F Einsle, et al. 2009 Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia Eur Arch Psychiatry Clin Neurosci 259 155 166 10.1007/s00406-009-0065-6
23. V Arolt P Zwanzger A Ströhle, et al. 2009 Das Forschungsnetzwerk PANIC-NET-Von einem besseren Verständnis neurobiologischer Mechanismen der Furchtregulation zu effektiverer psychotherapeutischer Behandlung in der Praxis Psychother Psych Med 59 124 131 10.1055/s-0029-1202781
24. B Botella A García-Palacios H Villa, et al. 2007 Virtual reality exposure in the treatment of panic disorder and agoraphobia: a controlled study Clin Psychol Psychother 14 164 175 10.1002/cpp.524 (Pubitemid 46951842)
25. L Gregg N Tarrier 2007 Virtual reality in mental health: a review of the literature Soc Psychiatry Psychiatr Epidemiol 42 343 354 10.1007/s00127-007- 0173-4 17431528 (Pubitemid 46767686)
26. G Riva 2005 Virtual reality in psychotherapy: review CyberPsychol Behav 8 220 230 10.1089/cpb.2005.8.220 15971972 (Pubitemid 40847799)
27. PMG Emmelkamp M Krijn AM Hulsbosch, et al. 2002 Virtual reality treatment versus exposure in vivo: a comparative evaluation in acrophobia Behav Res Ther 40 509 516 1:STN:280:DC%2BD383pvVSktg%3D%3D 10.1016/S0005-7967(01)00023-7 12038644 (Pubitemid 34270462)
28. A Mühlberger A Weik P Pauli, et al. 2006 One-session virtual reality exposure treatment for fear of flying: 1-year follow-up and graduation flight accompaniment effects Psychother Res 16 26 40 10.1080/10503300500090944 (Pubitemid 43135566)
29. BO Rothbaum L Hodges PL Anderson, et al. 2002 Twelve-month follow-up of virtual reality and standard exposure therapies for the fear of flying J Consult Clin Psychol 70 428 432 10.1037/0022-006X.70.2.428 11952201
30. V Starcevic 2008 Treatment of panic disorder: recent developments and current status Expert Rev Neurother 8 1219 1232 1:CAS:528:DC%2BD1cXpt1els7k%3D 10.1586/14737175.8.8.1219 18671666
31. KJ Ressler BO Rothbaum L Tannenbaum, et al. 2004 Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear Arch Gen Psychiatry 1 1136 1144 10.1001/archpsyc.61.11.1136 (Pubitemid 39463415)
32. MW Otto DF Tolin NM Simon, et al. 2009 Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder Biol Psychiatry 67 365 370 10.1016/j.biopsych.2009.07.036 19811776
33. AT Barker R Jalinous IL Freeston 1985 Non-invasive magnetic stimulation of human motor cortex Lancet 1 1106 1107 1:STN:280:DyaL2M3ht1Kjuw%3D%3D 10.1016/S0140-6736(85)92413-4 2860322
34. JE LeDoux P Cicchetti A Xagoraris, et al. 1990 The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning J Neurosci 10 1062 1069 1:STN:280:DyaK3c3ivF2jtQ%3D%3D 2329367
35. M Davis 1992 The role of the amygdala in fear and anxiety Annu Rev Neurosci 15 353 375 1:STN:280:DyaK383ks1Cmsw%3D%3D 10.1146/annurev.ne.15.030192. 002033 1575447
36. JM Gorman JM Kent GM Sullivan, et al. 2000 Neuroanatomical hypothesis of panic disorder, revised Am J Psychiatry 157 493 505 1:STN:280: DC%2BD3c3gsVSmuw%3D%3D 10.1176/appi.ajp.157.4.493 10739407 (Pubitemid 30191187)
37. KN Ochsner JJ Gross 2005 The cognitive control of emotion Trends Cogn Sci 9 242 249 10.1016/j.tics.2005.03.010 15866151 (Pubitemid 40615112)
38. AR Hariri SY Bookheimer JC Mazziotta 2000 Modulating emotional responses: effects of a neocortical network on the limbic system Neuroreport 11 43 48 1:STN:280:DC%2BD3c7kslCmsw%3D%3D 10.1097/00001756-200001170-00009 10683827
39. AR Hariri VS Mattay A Tessitore, et al. 2003 Neocortical modulation of the amygdala response to fearful stimuli Biol Psychiatry 53 494 501 10.1016/S0006-3223(02)01786-9 12644354 (Pubitemid 36331888)
40. SF Taylor KL Phan LR Decker, et al. 2003 Subjective rating of emotionally salient stimuli modulates neural activity Neuroimage 18 650 659 10.1016/S1053-8119(02)00051-4 12667842 (Pubitemid 36349415)
41. RJ Davidson H Abercrombie DJ Nutt, et al. 1999 Regional brain function, emotion and disorders of emotion Curr Opin Neurobiol 9 228 234 1:CAS:528:DyaK1MXjtVOit7w%3D 10.1016/S0959-4388(99)80032-4 10322186 (Pubitemid 29201797)
42. W Heller JB Nitschke 1998 The puzzle of regional brain activity in depression and anxiety: the importance of subtypes and comorbidity Cogn Emot 12 421 447 10.1080/026999398379664
43. J Van Honk A Tuiten M Van Den Hout, et al. 1998 Baseline salivary cortisol levels and preconscious selective attention for threat: a pilot study Psychoneuroendocrinology 23 741 747 10.1016/S0306-4530(98)00047-X 9854745 (Pubitemid 29009544)
44. J Van Honk A Tuiten R Verbaten, et al. 1999 Correlations among salivary testosterone, mood, and selective attention to threat in humans Horm Behav 36 17 24 10.1006/hbeh.1999.1521 10433883 (Pubitemid 29382843)
45. P Zwanzger AJ Fallgatter M Zavorotnyy, et al. 2009 Anxiolytic effects of transcranial magnetic stimulation-an alternative treatment option in anxiety disorders? J Neural Transm 116 767 775 10.1007/s00702-008-0162-0 19137237
46. M Garcia-Toro CJ Salva FM Crespi, et al. 2002 Panic disorder and transcranial magnetic stimulation Actas Esp Psiquiatr 30 221 224 1:STN:280:DC%2BD38vlvVyjsw%3D%3D 12217271
47. A Mantovani SH Lisanby F Pieraccini, et al. 2007 Repetitive transcranial magnetic stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression J Affect Disord 102 277 280 10.1016/j.jad.2006.11.027 17215046 (Pubitemid 47042168)
48. P Zwanzger C Minov R Ella, et al. 2002 Transcranial magnetic stimulation for panic Am J Psychiatry 159 315 316 10.1176/appi.ajp.159.2.315-a 11823280
49. P Zwanzger D Eser N Volkel, et al. 2007 Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4) Int J Neuropsychopharmacol 10 285 289 1:CAS:528:DC%2BD2sXhs1Cqs7Y%3D 10.1017/S146114570600695X 16817979
50. J Prasko R Zalesky M Bares, et al. 2007 The effect of repetitive transcranial magnetic stimulation (rTMS) add on serotonin reuptake inhibitors in patients with panic disorder: a randomized, double blind sham controlled study Neuro Endocrinol Lett 28 33 38 17277734
51. American Psychiatric Association (2000) Practice guidelines for the treatment of patients with major depressive disorder. http://www. psychiatryonline.com/pracGuide/pracGuideChapToc-7.aspx. Accessed 16 April 2010
52. DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (eds) (2009) für die Leitliniengruppe Unipolare Depression. S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression-Kurzfassung, 1. Auflage 2009. DGPPN, ÄZQ, AWMF-Berlin, Düsseldorf
53. DH Barlow JM Gorman MK Shear, et al. 2000 Cognitive-behavioral therapy, imipramine or their combination for panic disorder: a randomized controlled trial J Am Med Assoc 283 2529 2536 1:CAS:528:DC%2BD3cXjvVemurc%3D 10.1001/jama.283.19.2529
54. FJ van Apeldoorn ME Timmerman PP Mersch, et al. 2010 A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up J Clin Psychiatry 71 574 586 10.4088/JCP.08m04681blu 20492852